Listar por autor "Luño Fernández, Elisa"
Mostrando ítems 12-31 de 38
-
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.
Espinet, Blanca; Ferrer, A.; Bellosillo, B.; Nonell, L.; Luño Fernández, Elisa (American Association for Cancer Research, 2014) -
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry
Bernal del Castillo, Teresa; Martínez Camblor, Pablo; Sánchez García, Joaquín; Paz, Raquel de; Luño Fernández, Elisa; Nomdedeu, Benet; Ardanaz, María Teresa; Pedro, Carme; Amigo, M. L.; Xicoy, Blanca (Nature Publishing Group, 2015) -
The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis
Hernández Boluda, Juan Carlos; Pereira, Arturo; Gómez, Montse; Boque, Concepción; Luño Fernández, Elisa (Ferrata Storti Foundation : The European Hematology Association, 2014) -
Monosomal karyotype in MDS : explaining the poor prognosis?
Schanz, J.; Tüchler, H.; Solé Ristol, Francesc; Luño Fernández, Elisa (Nature Publishing Group, 2013) -
Results of treatment with Azacitidine in patients aged ≥75 years included in the Spanish Registry of Myelodysplastic Syndromes (MDS)
Xicoy, Blanca; Jiménez, María José; García, Olga; Bargay, Joan; Martínez Robles, Violeta; Brunet, Salut; Arilla, María Jesús; Pérez de Oteyza, Jaime; Andreu, Rafael; Luño Fernández, Elisa (Informa Healthcare, 2013-08-16)